Developing Drugs for Prevention of Chemotherapy-Induced Nausea and Vomiting: Draft Guidance from the FDA | Citedby Results | Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Developing Drugs for Prevention of Chemotherapy-Induced Nausea and Vomiting: Draft Guidance from the FDA

Clin Cancer Res (2021) 27 (22): 6072–6074.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

A study on the efficacy and safety of aprepitant injection in preventing and treating nausea and vomiting induced by platinum‐based chemotherapy in lung cancer

Yan Fei
Liu siwen
Li xiaoyou
Xu Xiaoyue
Wu Yuan
Shen Bo

Precision Medical Sciences (2024) 13 (1): 63.

Efficacy and safety of Aprepitant-containing triple therapy for the prevention and treatment of chemotherapy-induced nausea and vomiting: A meta-analysis

Min Zhang
Qing-Li Guo
Ting-Ting Zhang
Min Fu
Heng-Tai Bi
Jun-Yao Zhang
Kai-Li Zou

Medicine (2023) 102 (47): e35952.